Skip to main content

Peer Review reports

From: A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Original Submission
12 Jul 2016 Submitted Original manuscript
17 Jul 2016 Author responded Author comments - Hisashi Tanaka
Resubmission - Version 2
17 Jul 2016 Submitted Manuscript version 2
1 Feb 2017 Reviewed Reviewer Report - Herbert Loong
20 Mar 2017 Reviewed Reviewer Report - Suzanne Dahlberg
24 Jul 2017 Author responded Author comments - Hisashi Tanaka
Resubmission - Version 3
24 Jul 2017 Submitted Manuscript version 3
9 Aug 2017 Reviewed Reviewer Report - Herbert Loong
21 Sep 2017 Author responded Author comments - Hisashi Tanaka
Resubmission - Version 4
21 Sep 2017 Submitted Manuscript version 4
Publishing
11 Oct 2017 Editorially accepted
16 Oct 2017 Article published 10.1186/s12885-017-3684-8

You can find further information about peer review here.

Back to article page